Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma…
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent…
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Finance
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows…
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Page 323
Biotech
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Second Wave Portfolio (DGX, RXMD, APT)
Gavins Felicity
-
July 31, 2020
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Winds Down Probuphine sales In The US And Focuses On ProNeura® Product Development
MannKind Corporation (NASDAQ: MNKD) Starts Paediatric Enrolment For INHALE-1 Study And Enters Sale-Leaseback Deal
Sorrento Therapeutics Inc. (NASDAQ:SRNE) Receives $34 Million Government Contract For Development Of COVID-19 Treatment
Theravance Biopharma Inc. (NASDAQ: TBPH) Announce Phase 2b Izencitinib Dose-Finding Study Results in Ulcerative Colitis
Outlook Therapeutics Inc. (NASDAQ: OTLK) Presents NORSE II ONS-5010 Study Data...
Gavins Felicity
-
December 10, 2021
0
Pieris Pharmaceuticals Inc (NASDAQ: PIRS) Develops An Oral Inhaled Anticalin Protein...
Kate Hudson
-
June 29, 2021
0
Palisade Bio Inc (NASDAQ: PALI) Commences Dosing Of Patients In Phase...
Gavins Felicity
-
August 30, 2022
0
TriSalus Life Sciences Enters into an Asset Purchase Agreement under Which...
Gavins Felicity
-
August 13, 2020
0
IGM Biosciences Inc. (NASDAQ: IGM) Reports Progress in Development of its...
Gavins Felicity
-
February 21, 2022
0
1
...
322
323
324
...
326
Page 323 of 326
Recent Post
Sezzle (NASDAQ: SEZL) Shares Surge on Robust Q1 Earnings and Upgraded...
Kate Hudson
-
May 9, 2024
0
Sezzle Inc. (NASDAQ:SEZL) saw its stock price increase today primarily due to its strong first-quarter financial performance for 2024. The company reported...
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows...
May 8, 2024
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma...
May 7, 2024
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent...
May 2, 2024
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
May 1, 2024